Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

News Daily News

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19

March 22, 2022

Penumbra’s JET 7 Recall: A Kick Start to Change?

News Daily News

Penumbra’s JET 7 Recall: A Kick Start to Change?

December 01, 2021

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

News Conference News ACC 2021

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

May 17, 2021

Microvascular Thrombi Common in Patients Dying of COVID-19

News Daily News

Microvascular Thrombi Common in Patients Dying of COVID-19

Michael O'Riordan

January 27, 2021

COVID-19: TCTMD’s Daily Dispatch for January

News Daily News

COVID-19: TCTMD’s Daily Dispatch for January

January 01, 2021

News Daily News

Myocarditis Is Rare in COVID-19 Deaths, International Autopsy Data Suggest

November 05, 2020

Autopsy Study Finds Most COVID-19 Patients Have Macrophages in Myocardium

News Daily News

Autopsy Study Finds Most COVID-19 Patients Have Macrophages in Myocardium

October 02, 2020

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

News Daily News

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

July 23, 2020

Don’t Mistake Microthrombi for Myocarditis in COVID-19 STEMI, Case Report Warns

News Daily News

Don’t Mistake Microthrombi for Myocarditis in COVID-19 STEMI, Case Report Warns

July 22, 2020

Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response

News Daily News

Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response

June 25, 2020

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

June 25, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.